title: Biocompatibility of pure and mixed hydroxyapatite and α-tricalcium phosphate implanted in rabbit bone.
abstract: Calcium phosphates and hydroxyapatite, in particular, are used as substitute materials in experimental implantology. These materials are primarily used in hard tissue replacement because their chemical and crystallographic characteristics are considered to be similar to the mineral content, osteoconductivity and bioactivity of normal bone. Cytokines, such as interleukin (IL)-1, IL-6, IL-8, IL-10 and antimicrobial protein β-defensin-2 (βDef-2), are used as biomarkers of non-specific reactogenicity. Other biomarkers, including bone morphogenetic protein-2/4 (BMP-2/4), bone regeneration protein osteoprotegerin (OPG), bone matrix protein osteopontin (OP) and osteocalcin (OC), are regarded as specific factors of reactogenicity in bone substitution. The aim of our study was to assess the changes in the distribution and expression of the aforementioned proteins in the lower jaws of rabbits following implantation with pure hydroxyapatite (HAP), α-tricalcium phosphate (α-TCP) or a mix of the two (HAP/α-TCP) manufactured under different temperatures. Our results reveal osteoblast proliferation and regions of granulation tissue formation between biomaterial granules close to the original implantation site, but in the control tissue these changes were less noticeable. Our study showed low variability in the distribution of βDef-2, OPG and all of the tested interleukins and these proteins were less expressed than BMP2/4, OP and OC. But across all experiments, no statistically significant difference in mean βDef-2, IL-1, IL-6, IL-8, IL-10, OP, OC, BMP-2/4 and OPG expression in osteocytes was detected between experimental and control groups. We concluded that pure and mixed HAP and α-TCP sintered at different temperatures do not affect the production of cytokines and bone-specific proteins; regions with osteoblast proliferation and low levels of anti-inflammatory cytokines IL-6 and IL-10 indicates better biocompatibility for HAP/α-TCP and α-TCP-2 biomaterials and the moderate number of BMP-2/4- and a prevalence of OC- and OP-positive osteocytes in experimental tissues implanted with HAP at 3 months after implantation indicates potential bone regeneration stimulated by pure HAP.
authors: Riga Stradins University, Dzirciema str.16, Riga, 1007, Latvia, jolantavmz@gmail.com.
authors: Jolanta
authors: J
authors: Vamze
authors: Mara
authors: M
authors: Pilmane
authors: Andrejs
authors: A
authors: Skagers
mesh_terms: D000818:Animals; D001861:Bone Regeneration / Q000187:drug effects / Q000276:immunology*; D018786:Bone Substitutes / Q000737:chemistry / Q000494:pharmacology*; D002130:Calcium Phosphates / Q000737:chemistry / Q000494:pharmacology*; D016207:Cytokines / Q000276:immunology*; D017886:Durapatite / Q000737:chemistry / Q000494:pharmacology*; D007155:Immunologic Factors / Q000276:immunology; D007568:Jaw / Q000187:drug effects / Q000276:immunology*; D008297:Male; D056948:Orthognathic Surgical Procedures; D011817:Rabbits; D016896:Treatment Outcome
chemical_list: D018786:Bone Substitutes; D002130:Calcium Phosphates; D016207:Cytokines; D007155:Immunologic Factors; C485828:alpha-tricalcium phosphate; D017886:Durapatite
references: J Biomater Appl. 2008 Nov;23(3):197-212
references: 18996965
references: Nature. 2003 Oct 30;425(6961):977-80
references: 14586470
references: J Histochem Cytochem. 1981 Apr;29(4):577-80
references: 6166661
references: J Immunol. 2001 Feb 1;166(3):1482-91
references: 11160187
references: Planta. 2002 Dec;216(2):193-202
references: 12447532
references: Cell. 1997 Apr 18;89(2):309-19
references: 9108485
references: Thorax. 1995 May;50(5):551-4
references: 7541167
references: Biomaterials. 2011 Jun;32(17):4067-75
references: 21421269
references: Expert Rev Med Devices. 2005 Jan;2(1):87-101
references: 16293032
references: Ann Clin Biochem. 2000 Jul;37 ( Pt 4):432-46
references: 10902858
references: Stomatologija. 2009;11(4):113-8
references: 20179398
references: Medicina (Kaunas). 2011;47(10):560-5
references: 22186120
references: FEMS Immunol Med Microbiol. 2012 Apr;64(3):374-81
references: 22171654
references: J Orthop Res. 2001 Jul;19(4):621-8
references: 11518271
references: Crit Rev Oral Biol Med. 2000;11(3):279-303
references: 11021631
references: Clin Orthop Relat Res. 2007 Jul;460:240-52
references: 17620815
references: Eur Cell Mater. 2010 Jul 01;20:1-12
references: 20574942
references: Peptides. 2008 Dec;29(12):2083-9
references: 18824048
references: J Oral Pathol Med. 2004 May;33(5):278-85
references: 15078488
references: Immunogenetics. 1997;46(2):120-8
references: 9162098
references: J Biol Chem. 2008 Jul 25;283(30):20948-58
references: 18436533
references: Curr Protein Pept Sci. 2005 Feb;6(1):7-21
references: 15638765